Retrospective analysis of assigned treatment
OtherRetrospective analysis of assigned treatment will be performed
NCT Number: NCT07031466
This study consists of two parts - retrospective and prospective. The aim of this study is to assess the quality of life in bio-psycho-social dimensions in patients after eCPR (extracorporeal cardiopulmonary resuscitation), in relation to their neurological outcome after the end of treatment and discharge from the Ostrava University Hospital (FNO). The study will focus on patients who underwent extracorporeal membrane oxygenation (ECMO) support after out-of-hospital cardiac arrest (OHCA) in the years 2022-2024.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
University Hospital Ostrava, Ostrava, Moravian-Silesian Region, Czechia
Retrospective study Quantitative evaluation using data analysis from documentation. Patients on ECMO after OHCA in the period 1. 1. 2022 - 31. 12. 2024 will be evaluated based on data from the documentation. Analysis of data from the documentation of selected patients will be performed, evaluating demographic data, comorbidities, duration of ECMO support, mortality, Cerebral Performance Category (CPC) score 30 days after CPR.
Prospective study Quantitative assessment using validated questionnaire tools Patients connected to ECMO after OHCA in the period 1. 1. 2022 - 31. 12. 2024, in whom a CPC score >3 was detected after the 30th day from cardiac arrest and who were discharged from the FNO. As part of patient dispensary, these patients are electively invited to the PICS outpatient clinic in the FNO Ostrava. Individual interviews (filling out questionnaires) will be performed after obtaining informed consent in the Post-Intensive Care Syndrome (PICS) outpatient clinic at the University Hospital Ostrava, or telephone interviews conducted by the attending physician.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Retrospective analysis of assigned treatment will be performed
The quality of life will be assessed using the SF-36 (Short-Form Health Subject Questionnaire).
The quality of life will be assessed using the EQ-5D (European Quality of Life Questionnaire)
Hospital Anxiety and Depression will be assessed using the HADS (Hospital Anxiety and Depression Scale)
Time frame: 30 days
Quality of Life in patients after eCPR will be assessed using the SF-36 questionnaire 30 days after eCPR
Time frame: 30 days
Quality of Life in patients after eCPR will be assessed using the EQ-5D questionnaire 30 days after eCPR
Time frame: 30 days
Hospital Anxiety and Depression Scale (HADS) in patients after eCPR will be assessed using the EQ-5D questionnaire 30 days after eCPR
University Hospital Ostrava
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07524881
Cardiac Arrest (CA), Cardiovascular Diseases
Sultangazi, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07023159
Cardiac Arrest (CA), Cardiovascular Diseases
Istanbul, Sultangazi, Turkey (Türkiye)
View Trial DetailsNCT07579390
Acute Kidney Failure, Acute Kidney Injury
Brisbane, Australia
View Trial DetailsNCT07589504
Cardiac Arrest (CA), Cardiovascular Diseases
Bologna, Emilia-Romagna, Italy
View Trial Details